Ireland
--:--IST
Priya Life Science Medicines register
Registers› Irish medicines ›Nithiodote Solution for Injection
Medicines register · Ireland

Nithiodote Solution for Injection

Authorisation PA22874/003/001 · Hope Pharmaceuticals Ltd

Source: Health Products Regulatory Authority (HPRA), open dataset, CC BY 4.0. HPRA list dated 22 Nov 2026
Licence holder
Hope Pharmaceuticals Ltd (all products →)
Active substances
SODIUM NITRITE, Sodium thiosulfate
Clinical trials
5 clinical trials →
Dosage form
Solution for injection
Route of administration
Intravenous use
ATC codes
V03AB, V03AB06, V03AB08
First authorised
06/07/2018
Prescription status
Product subject to prescription which may not be renewed (A)
Supply
Supply through pharmacies only
Legal basis
Well-established use application (Article 10a of Directive No 2001/83/EC)

SODIUM NITRITE: supply and approvals

2 authorised products on the HPRA list contain SODIUM NITRITE. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.

EU shortage (EMA)
No entry in the EMA shortage catalogue (checked 21 Nov 2026)
US shortage (FDA)
No entry in the FDA drug shortage list (checked 21 Nov 2026)
Germany (BfArM)
No entry in the BfArM supply notices (checked 21 Nov 2026)

Registers: EU shortages · US shortages · German shortages · EMA approvals

Sodium thiosulfate: supply and approvals

3 authorised products on the HPRA list contain Sodium thiosulfate. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.

EU shortage (EMA)
No entry in the EMA shortage catalogue (checked 21 Nov 2026)
US shortage (FDA)
No entry in the FDA drug shortage list (checked 21 Nov 2026)
Germany (BfArM)
No entry in the BfArM supply notices (checked 21 Nov 2026)

Registers: EU shortages · US shortages · German shortages · EMA approvals

About this licence

National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 8 years (since 6 July 2018). The HPRA list marks it as not marketed: it is licensed but the holder has not reported it as on sale.

Other medicines with SODIUM NITRITE in Ireland

1 other product on the HPRA list contains SODIUM NITRITE, from 1 licence holder; 0 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.

MedicineLicence holderLicenceStatus
Sodium Nitrite Hope Pharmaceuticals 30 mg/mL Solution for InjectionHope Pharmaceuticals LtdNational authorisation (PA)Not marketed

Other medicines with Sodium thiosulfate in Ireland

2 other products on the HPRA list contain Sodium thiosulfate, from 2 licence holders; 0 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.

MedicineLicence holderLicenceStatus
Pedmarqsi 80 mg/mL solution for infusionNorgine B.V.Centralised EU authorisationNot stated
Sodium Thiosulfate Hope Pharmaceuticals 250 mg/mL Solution for InjectionHope Pharmaceuticals LtdNational authorisation (PA)Not marketed

Other substances in ATC group V03AB

The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 12 other active substances share the group V03AB with this product:

Hydroxocobalamin (2) · Naloxone hydrochloride dihydrate (2) · Flumazenil (1) · Sugammadex (1) · Fomepizole sulphate (1) · Methylthioninium chloride (1) · NALOXONE HYDROCHLORIDE (1) · Andexanet alfa (1) · Acetylcysteine (1) · Potassium iodide (1) · Idarucizumab (1) · Protamine sulphate (1)

Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.

The licence holder

Hope Pharmaceuticals Ltd holds 3 products on the HPRA list, with 2 different active substances; 0 of the products are marked as marketed.

Shortages and approvals, every Friday

One email a week with ongoing EU and US medicine shortages, new EMA and FDA approvals and clinical trials recruiting in Ireland.

Free. Unsubscribe from any email with one click. See our privacy policy.

This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.

How this page is built

The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.

This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 22 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.